UASt regulatory sequences drive expression of an inverted repeat.
Larvae expressing Arf51FGD13822 under the control of Scer\GAL4Hml.PG show normal rates of encapsulation of eggs when parasitised by the avirulent L. boulardi wasp strain G486.
Arf6GD13822, Dcr-2UAS.cDa, Scer\GAL4GMR.PF has increased cell death phenotype
Arf6GD13822, Dcr-2UAS.cDa, Scer\GAL4GMR.PF has retina phenotype, enhanceable by In(1)rst3/+
Arf6GD13822, Dcr-2UAS.cDa, Scer\GAL4GMR.PF has retina phenotype, enhanceable by hbs459/hbs[+]
Arf6GD13822, Dcr-2UAS.cDa, Scer\GAL4GMR.PF has ommatidium phenotype, enhanceable by AsapKG03963/CG30372[+]
Arf6GD13822, Dcr-2UAS.cDa, Scer\GAL4GMR.PF has primary pigment cell phenotype, enhanceable by AsapKG03963/CG30372[+]
Arf6GD13822, Dcr-2UAS.cDa, Scer\GAL4GMR.PF has secondary pigment cell phenotype, enhanceable by AsapKG03963/CG30372[+]
Arf6GD13822, Dcr-2UAS.cDa, Scer\GAL4GMR.PF has tertiary pigment cell phenotype, enhanceable by AsapKG03963/CG30372[+]
Arf6GD13822, Dcr-2UAS.cDa, Scer\GAL4GMR.PF has cone cell phenotype, enhanceable by AsapKG03963/CG30372[+]
Arf6GD13822, Dcr-2UAS.cDa, Scer\GAL4GMR.PF has interommatidial precursor cell phenotype, enhanceable by AsapKG03963/CG30372[+]
Arf6GD13822, Dcr-2UAS.cDa, Scer\GAL4GMR.PF has retina phenotype, enhanceable by IqsecT1032/siz[+]
Arf6GD13822, Dcr-2UAS.cDa, Scer\GAL4GMR.PF has ommatidium phenotype, enhanceable by IqsecT1032/siz[+]
Arf6GD13822, Dcr-2UAS.cDa, Scer\GAL4GMR.PF has primary pigment cell phenotype, enhanceable by IqsecT1032/siz[+]
Arf6GD13822, Dcr-2UAS.cDa, Scer\GAL4GMR.PF has secondary pigment cell phenotype, enhanceable by IqsecT1032/siz[+]
Arf6GD13822, Dcr-2UAS.cDa, Scer\GAL4GMR.PF has retina phenotype, enhanceable by ArfGAP3e01250/CG6838[+]
Arf6GD13822, Dcr-2UAS.cDa, Scer\GAL4GMR.PF has tertiary pigment cell phenotype, enhanceable by IqsecT1032/siz[+]
Arf6GD13822, Dcr-2UAS.cDa, Scer\GAL4GMR.PF has cone cell phenotype, enhanceable by IqsecT1032/siz[+]
Arf6GD13822, Dcr-2UAS.cDa, Scer\GAL4GMR.PF has interommatidial precursor cell phenotype, enhanceable by IqsecT1032/siz[+]
Arf6GD13822, Dcr-2UAS.cDa, Scer\GAL4GMR.PF has retina phenotype, enhanceable by Efa6KO1/CG31158[+]
Arf6GD13822, Dcr-2UAS.cDa, Scer\GAL4GMR.PF has ommatidium phenotype, enhanceable by Efa6KO1/CG31158[+]
Arf6GD13822, Dcr-2UAS.cDa, Scer\GAL4GMR.PF has primary pigment cell phenotype, enhanceable by Efa6KO1/CG31158[+]
Arf6GD13822, Dcr-2UAS.cDa, Scer\GAL4GMR.PF has secondary pigment cell phenotype, enhanceable by Efa6KO1/CG31158[+]
Arf6GD13822, Dcr-2UAS.cDa, Scer\GAL4GMR.PF has tertiary pigment cell phenotype, enhanceable by Efa6KO1/CG31158[+]
Arf6GD13822, Dcr-2UAS.cDa, Scer\GAL4GMR.PF has cone cell phenotype, enhanceable by Efa6KO1/CG31158[+]
Arf6GD13822, Dcr-2UAS.cDa, Scer\GAL4GMR.PF has interommatidial precursor cell phenotype, enhanceable by Efa6KO1/CG31158[+]
Arf6GD13822, Dcr-2UAS.cDa, Scer\GAL4GMR.PF has ommatidium phenotype, enhanceable by ArfGAP3e01250/CG6838[+]
Arf6GD13822, Dcr-2UAS.cDa, Scer\GAL4GMR.PF has retina phenotype, enhanceable by Rho172F/Rho1[+]
Arf6GD13822, Dcr-2UAS.cDa, Scer\GAL4GMR.PF has ommatidium phenotype, enhanceable by Rho172F/Rho1[+]
Arf6GD13822, Dcr-2UAS.cDa, Scer\GAL4GMR.PF has primary pigment cell phenotype, enhanceable by ArfGAP3e01250/CG6838[+]
Arf6GD13822, Dcr-2UAS.cDa, Scer\GAL4GMR.PF has secondary pigment cell phenotype, enhanceable by ArfGAP3e01250/CG6838[+]
Arf6GD13822, Dcr-2UAS.cDa, Scer\GAL4GMR.PF has tertiary pigment cell phenotype, enhanceable by ArfGAP3e01250/CG6838[+]
Arf6GD13822, Dcr-2UAS.cDa, Scer\GAL4GMR.PF has cone cell phenotype, enhanceable by ArfGAP3e01250/CG6838[+]
Arf6GD13822, Dcr-2UAS.cDa, Scer\GAL4GMR.PF has interommatidial precursor cell phenotype, enhanceable by ArfGAP3e01250/CG6838[+]
Arf6GD13822, Dcr-2UAS.cDa, Scer\GAL4GMR.PF has retina phenotype, enhanceable by AsapKG03963/CG30372[+]
Arf6GD13822, Dcr-2UAS.cDa, Scer\GAL4GMR.PF has ommatidium phenotype
Arf6GD13822, Dcr-2UAS.cDa, Scer\GAL4GMR.PF has retina phenotype
Arf6GD13822, Dcr-2UAS.cDa, Scer\GAL4GMR.PF has cone cell phenotype
Arf6GD13822, Dcr-2UAS.cDa, Scer\GAL4GMR.PF has secondary pigment cell phenotype
Arf6GD13822, Dcr-2UAS.cDa, Scer\GAL4GMR.PF has tertiary pigment cell phenotype
Arf6GD13822, Dcr-2UAS.cDa, Scer\GAL4GMR.PF has primary pigment cell phenotype
Arf6GD13822, Dcr-2UAS.cDa, Scer\GAL4GMR.PF has actin cytoskeleton phenotype
Arf6GD13822, Dcr-2UAS.cDa, Scer\GAL4GMR.PF has interommatidial precursor cell phenotype
Arf6ΔKG1, Arf6GD13822, Dcr-2UAS.cDa, Scer\GAL4GMR.PF has retina phenotype
Compared with wild-type, interommatidial precursor cells (IPCs) co-expressing Arf51FGD13822 and Dcr-2Scer\UAS.cDa under the control of Scer\GAL4GMR.PF exhibit weak cell extensions that seldom extend sufficiently far to reach a target primary pigment cell and are often retracted. When contact is occasionally achieved by the mutant cells, in contrast to wild-type, the IPC-primary pigment cell interface fails to rapidly widen and is commonly lost. Rather than generating one concerted extension, IPCs co-expressing Arf51FGD13822 and Dcr-2Scer\UAS.cDa via Scer\GAL4GMR.PF typically produce multiple small extensions or none at all. Arf51FGD13822-expression also induces some ectopic apoptosis prior to 20 h after puparium formation (APF). Impaired cell intercalation disrupts the final arrangement of cells in mature Scer\GAL4GMR.PF>Arf51FGD13822, Dcr-2Scer\UAS.cDa eyes: few secondary or tertiary niches are correctly occupied, IPCs frequently cluster into multiple rows, and the IPC lattice is poorly organised, leading to "fusion" of some ommatidia. Minor defects in cone and primary pigment cell organization and orientation are also present at low frequency.
The patterning defects in retinas co-expressing Arf51FGD13822 and Dcr-2Scer\UAS.cDa under the control of Scer\GAL4GMR.PF is enhanced by heterozygosity for Arf51FΔKG1.
The patterning defects in retinas co-expressing Arf51FGD13822 and Dcr-2Scer\UAS.cDa under the control of Scer\GAL4GMR.PF is enhanced by heterozygosity for In(1)rst3.
The patterning defects in retinas co-expressing Arf51FGD13822 and Dcr-2Scer\UAS.cDa under the control of Scer\GAL4GMR.PF is enhanced by heterozygosity for hbs459.
The eye mis-patterning phenotype resulting from the co-expression of Arf51FGD13822 with Dcr-2Scer\UAS.cDa under the control of Scer\GAL4GMR.PF is significantly enhanced in ArfGAP3e01250 heterozygotes. The number of correctly patterned secondary and tertiary cell is reduced. The total number of interommatidial precursor cells (IPCs) does not differ markedly from the wild-type number of 12, indicating that the enhancement is due to specifically to increased disorder in IPC patterning. Additionally, errors in the placement of three bristle groups about each ommatidium and errors in primary pigment cell and cone cell patterning and ommatidial rotation are modestly enhanced.
The eye mis-patterning phenotype resulting from the co-expression of Arf51FGD13822 with Dcr-2Scer\UAS.cDa under the control of Scer\GAL4GMR.PF is significantly enhanced in Asap1KG03963 heterozygotes. The number of correctly patterned secondary and tertiary cell is reduced. The total number of interommatidial precursor cells (IPCs) does not differ markedly from the wild-type number of 12, indicating that the enhancement is due to specifically to increased disorder in IPC patterning. Additionally, errors in the placement of three bristle groups about each ommatidium and errors in primary pigment cell and cone cell patterning and ommatidial rotation are modestly enhanced.
The eye mis-patterning phenotype resulting from the co-expression of Arf51FGD13822 with Dcr-2Scer\UAS.cDa under the control of Scer\GAL4GMR.PF is significantly enhanced in sizT1032 heterozygotes. The number of correctly patterned secondary and tertiary cell is reduced. The total number of interommatidial precursor cells (IPCs) does not differ markedly from the wild-type number of 12, indicating that the enhancement is due to specifically to increased disorder in IPC patterning. Additionally, errors in the placement of three bristle groups about each ommatidium and errors in primary pigment cell and cone cell patterning and ommatidial rotation are modestly enhanced.
The eye mis-patterning phenotype resulting from the co-expression of Arf51FGD13822 with Dcr-2Scer\UAS.cDa under the control of Scer\GAL4GMR.PF is significantly enhanced in Efa6KO1 heterozygotes. The number of correctly patterned secondary and tertiary cell is reduced. The total number of interommatidial precursor cells (IPCs) does not differ markedly from the wild-type number of 12, indicating that the enhancement is due to specifically to increased disorder in IPC patterning. Additionally, errors in the placement of three bristle groups about each ommatidium and errors in primary pigment cell and cone cell patterning and ommatidial rotation are modestly enhanced.
Compared with wild-type, the actin cytoskeleton is less well-organised in retinal cells co-expressing Arf51FGD13822 with Dcr-2Scer\UAS.cDa under the control of Scer\GAL4GMR.PF.
A mild, though not significant enhancement of the ommatidium-phenotype resulting from the co-expression of Arf51FGD13822 with Dcr-2Scer\UAS.cDa under the control of Scer\GAL4GMR.PF is observed in a Rac1J11, Rac2Δ, MtlΔ heterozygous background.
Heterozygosity for Rho172F enhances the patterning defects in the retina of flies co-expressing Arf51FGD13822 with Dcr-2Scer\UAS.cDa under the control of Scer\GAL4GMR.PF.
The ommatidial patterning defects resulting from the co-expression of Arf51FGD13822 with Dcr-2Scer\UAS.cDa driven by Scer\GAL4GMR.PF are mildly enhanced in Df(3R)Exel8194 heterozygotes. However, the genetic interaction does not achieve statistical significance.